{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:02:43Z","timestamp":1784264563202,"version":"3.55.0"},"reference-count":109,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Universidad Cooperativa de Colombia","award":["INV3229"],"award-info":[{"award-number":["INV3229"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rheumatological systemic autoimmune diseases constitute a significant health problem globally due to their chronicity, potentially permanent incapacity and higher mortality rates. Rheumatoid arthritis and systemic lupus erythematosus are among the most common of these diseases. Although there is a substantial body of research on these autoimmune diseases, there is still a need to identify better biomarkers of disease activity and progression. In this context, gelsolin and high-density lipoproteins arise as novel biomarkers from the perspective of immunomodulation and their role in the immunopathology of autoimmune diseases. Gelsolin is an actin cytoskeleton remodeling protein involved in immune regulatory mechanisms related to inflammation. High-density lipoproteins are plasmatic cargo molecules involved in reverse lipid transport, whereas their study in autoimmunity has focused on their value as cardiovascular risk predictors. However, new functions of these proteins related to immune and inflammation regulation have also been described recently. Therefore, this review aims to provide insight into the role of these biomolecules and their implications in the immunopathology and immunomodulation of autoimmune diseases from the perspective of rheumatoid arthritis and systemic lupus erythematosus.<\/jats:p>","DOI":"10.1093\/oxfimm\/iqag002","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:51:07Z","timestamp":1769086267000},"source":"Crossref","is-referenced-by-count":1,"title":["Exploring the role of gelsolin and high-density lipoproteins in autoimmune diseases: spotlight on rheumatoid arthritis and systemic lupus erythematosus"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-424X","authenticated-orcid":false,"given":"Juli\u00e1n","family":"P\u00e9rez-Ocampo","sequence":"first","affiliation":[{"name":"Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia , Medell\u00edn, 050016,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9200-5698","authenticated-orcid":false,"given":"Juan C","family":"Hernandez","sequence":"additional","affiliation":[{"name":"Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia , Medell\u00edn, 050016,","place":["Colombia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"2026030314345519700_iqag002-B1","first-page":"333","author":"World Health Organization","year":"2006"},{"key":"2026030314345519700_iqag002-B2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.29262\/ram.v68i4.984","article-title":"Enfermedades reum\u00e1ticas y alergias, la dualidad del sistema inmunol\u00f3gico","volume":"68","author":"S\u00e1nchez-Zuno","year":"2021","journal-title":"Ram"},{"key":"2026030314345519700_iqag002-B3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"2026030314345519700_iqag002-B4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-024-01952-8","article-title":"Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders","volume":"9","author":"Song","year":"2024","journal-title":"Sig Transduct Target Ther"},{"key":"2026030314345519700_iqag002-B5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2020.03.007","article-title":"Challenges, progress, and prospects of developing therapies to treat autoimmune diseases","volume":"181","author":"Fugger","year":"2020","journal-title":"Cell"},{"key":"2026030314345519700_iqag002-B6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2026030314345519700_iqag002-B7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/kjm2.12578","article-title":"Emerging roles of plasma gelsolin in tumorigenesis and modulating the tumor microenvironment","volume":"38","author":"Hsieh","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"2026030314345519700_iqag002-B8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/cells10051061","article-title":"HDL in immune-inflammatory responses: implications beyond cardiovascular diseases","volume":"10","author":"Bonacina","year":"2021","journal-title":"Cells"},{"key":"2026030314345519700_iqag002-B9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/med.20231","article-title":"Multifunctional roles of gelsolin in health and diseases","volume":"32","author":"Li","year":"2012","journal-title":"Med Res Rev"},{"key":"2026030314345519700_iqag002-B10","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/erm.2018.7","article-title":"Structure, regulation and related diseases of the actin-binding protein gelsolin","volume":"20","author":"Feldt","year":"2019","journal-title":"Expert Rev Mol Med"},{"key":"2026030314345519700_iqag002-B11","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3390\/ijms19092516","article-title":"Plasma gelsolin: indicator of inflammation and its potential as a diagnostic tool and therapeutic target","volume":"19","author":"Piktel","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026030314345519700_iqag002-B12","first-page":"bio027557","article-title":"Gelsolin regulates proliferation, apoptosis and invasion in natural killer\/T-cell lymphoma cells","volume":"7","author":"Guo","year":"2018","journal-title":"Biol Open"},{"key":"2026030314345519700_iqag002-B13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/0929866530666230124113639","article-title":"Gelsolin inhibits the proliferation of colon cancer cells by enhancing the expression of TNFR2\/CASP10 as a death receptor pathway","volume":"30","author":"Wang","year":"2023","journal-title":"Protein Pept Lett"},{"key":"2026030314345519700_iqag002-B14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1742-2094-8-118","article-title":"Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury","volume":"8","author":"Zhang","year":"2011","journal-title":"J Neuroinflammation"},{"key":"2026030314345519700_iqag002-B15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/mol.113.087403","article-title":"Structural insights into phospholipase C-\u03b2 function","volume":"84","author":"Lyon","year":"2013","journal-title":"Mol Pharmacol"},{"key":"2026030314345519700_iqag002-B16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000456043","article-title":"Gelsolin inhibits the inflammatory process induced by lps","volume":"41","author":"Cheng","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"2026030314345519700_iqag002-B17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2015.08.006","article-title":"Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis","volume":"287","author":"Kevin Li-Chun","year":"2015","journal-title":"J Neuroimmunol"},{"key":"2026030314345519700_iqag002-B18","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/emboj\/17.5.1362","article-title":"Gelsolin is a downstream effector of rac for fibroblast motility","volume":"17","author":"Azuma","year":"1998","journal-title":"Embo J"},{"key":"2026030314345519700_iqag002-B19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1083\/jcb.138.4.811","article-title":"Gelsolin modulates phospholipase C activity in vivo through phospholipid binding","volume":"138","author":"Sun","year":"1997","journal-title":"J Cell Biol"},{"key":"2026030314345519700_iqag002-B20","first-page":"2415","article-title":"Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers","volume":"7","author":"Thor","year":"2001","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"2026030314345519700_iqag002-B21","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/cells10071831","article-title":"The RHO family GTPases: mechanisms of regulation and signaling","volume":"10","author":"Mosaddeghzadeh","year":"2021","journal-title":"Cells"},{"key":"2026030314345519700_iqag002-B22","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fimmu.2020.01066","article-title":"Phagocytosis: our current understanding of a universal biological process","volume":"11","author":"Uribe-Querol","year":"2020","journal-title":"Front Immunol"},{"key":"2026030314345519700_iqag002-B23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.immuni.2016.02.026","article-title":"Phagocytosis: an immunobiologic process","volume":"44","author":"Gordon","year":"2016","journal-title":"Immunity"},{"key":"2026030314345519700_iqag002-B24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/imr.13173","article-title":"The formation and function of the neutrophil phagosome","volume":"314","author":"Naish","year":"2023","journal-title":"Immunol Rev"},{"key":"2026030314345519700_iqag002-B25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11883-022-01012-y","article-title":"The role of high-density lipoprotein cholesterol in 2022","volume":"24","author":"Sirtori","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"2026030314345519700_iqag002-B26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.17533\/udea.iatreia.v30n4a06","article-title":"Inflamaci\u00f3n y respuesta inmune innata: participaci\u00f3n de las lipoprote\u00ednas de alta densidad*","volume":"30","author":"Mar\u00edn-Palma","year":"2017","journal-title":"Iatreia"},{"key":"2026030314345519700_iqag002-B27","volume-title":"StatPearls","author":"Bailey","year":"2023"},{"key":"2026030314345519700_iqag002-B28","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.3892\/mmr.2015.3930","article-title":"High-density lipoprotein synthesis and metabolism (review)","volume":"12","author":"Zhou","year":"2015","journal-title":"Mol Med Rep"},{"key":"2026030314345519700_iqag002-B29","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"2026030314345519700_iqag002-B30","first-page":"251","article-title":"Paraoxonasa: sus m\u00faltiples funciones y regulaci\u00f3n farmacol\u00f3gica","volume":"81","author":"Fridman","year":"2011","journal-title":"Arch Cardiol M\u00e9xico"},{"key":"2026030314345519700_iqag002-B31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/icb.2009.112","article-title":"HDL and immunomodulation: an emerging role of HDL against atherosclerosis","volume":"88","author":"Yu","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"2026030314345519700_iqag002-B32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/ATVBAHA.107.160606","article-title":"Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells","volume":"28","author":"Norata","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026030314345519700_iqag002-B33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/ATVBAHA.108.183442","article-title":"Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity","volume":"29","author":"Wilhelm","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026030314345519700_iqag002-B34","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tcb.2020.01.009","article-title":"Lipid rafts: controversies resolved, mysteries remain","volume":"30","author":"Levental","year":"2020","journal-title":"Trends Cell Biol"},{"key":"2026030314345519700_iqag002-B35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1194\/jlr.M600428-JLR200","article-title":"Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages","volume":"48","author":"Koseki","year":"2007","journal-title":"J Lipid Res"},{"key":"2026030314345519700_iqag002-B36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ceb.2016.01.010","article-title":"Functional crosstalk between membrane lipids and TLR biology","volume":"39","author":"K\u00f6berlin","year":"2016","journal-title":"Curr Opin Cell Biol"},{"key":"2026030314345519700_iqag002-B37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12617","article-title":"Lipid rafts in immune signalling: current progress and future perspective","volume":"149","author":"Varshney","year":"2016","journal-title":"Immunology"},{"key":"2026030314345519700_iqag002-B38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2023.03.012","article-title":"Role and therapeutic potential of gelsolin in atherosclerosis","volume":"178","author":"Zhang","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"2026030314345519700_iqag002-B39","doi-asserted-by":"crossref","first-page":"e001242","DOI":"10.1136\/lupus-2024-001242","article-title":"Assessment of the role of high-density lipoproteins and their immunomodulatory activity in systemic lupus erythematosus immunopathology","volume":"11","author":"P\u00e9rez-Ocampo","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026030314345519700_iqag002-B40","doi-asserted-by":"publisher","first-page":"1254753","DOI":"10.3389\/fimmu.2023.1254753","article-title":"Dyslipidemia in rheumatoid arthritis: the possible mechanisms","volume":"14","author":"Yan","year":"2023","journal-title":"Front Immunol"},{"key":"2026030314345519700_iqag002-B41","doi-asserted-by":"publisher","first-page":"1362459","DOI":"10.3389\/fimmu.2024.1362459","article-title":"How do sphingosine-1-phosphate affect immune cells to resolve inflammation?","volume":"15","author":"Sun","year":"2024","journal-title":"Front Immunol"},{"key":"2026030314345519700_iqag002-B42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5415\/apallergy.0000000000000128","article-title":"Immunological mechanisms of tolerance: central, peripheral and the role of T and B cells","volume":"13","author":"Meng","year":"2023","journal-title":"Asia Pac Allergy"},{"key":"2026030314345519700_iqag002-B43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"2026030314345519700_iqag002-B44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/cmi.2017.137","article-title":"Genetic and epigenetic influences on the loss of tolerance in autoimmunity","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"2026030314345519700_iqag002-B45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"The Lancet"},{"key":"2026030314345519700_iqag002-B46","doi-asserted-by":"crossref","first-page":"899372","DOI":"10.3389\/fimmu.2022.899372","article-title":"Preclinical autoimmune disease: a comparison of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis and type 1 diabetes","volume":"13","author":"Frazzei","year":"2022","journal-title":"Front Immunol"},{"key":"2026030314345519700_iqag002-B47","doi-asserted-by":"crossref","first-page":"103386","DOI":"10.1016\/j.autrev.2023.103386","article-title":"Functional autoantibodies: definition, mechanisms, origin and contributions to autoimmune and non-autoimmune disorders","volume":"22","author":"Yu","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026030314345519700_iqag002-B48","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/ewjm.174.2.118","article-title":"Tolerance and autoimmunity","volume":"174","author":"Mackay","year":"2001","journal-title":"West J Med"},{"key":"2026030314345519700_iqag002-B49","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"2026030314345519700_iqag002-B50","volume-title":"StatPearls","author":"Chauhan","year":"2023"},{"key":"2026030314345519700_iqag002-B51","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/joim.13058","article-title":"The importance of differences; on environment and its interactions with genes and immunity in the causation of rheumatoid arthritis","volume":"287","author":"Klareskog","year":"2020","journal-title":"J Intern Med"},{"key":"2026030314345519700_iqag002-B52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"2026030314345519700_iqag002-B53","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"2026030314345519700_iqag002-B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primer"},{"key":"2026030314345519700_iqag002-B55","volume-title":"Firestein & Kelley\u2019s Textbook of Rheumatology, 2-Volume Set","author":"Gary S. Firestein, Ralph C. Budd, Sherine E. Gabriel","year":"2020"},{"key":"2026030314345519700_iqag002-B56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/exd.12428","article-title":"Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus","volume":"23","author":"Zahn","year":"2014","journal-title":"Exp Dermatol"},{"key":"2026030314345519700_iqag002-B57","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"2026030314345519700_iqag002-B58","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.4049\/jimmunol.174.6.3326","article-title":"Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation","volume":"174","author":"Decker","year":"2005","journal-title":"J Immunol"},{"key":"2026030314345519700_iqag002-B59","doi-asserted-by":"crossref","first-page":"e26495","DOI":"10.1371\/journal.pone.0026495","article-title":"New inflammation-related biomarkers during malaria infection","volume":"6","author":"Kassa","year":"2011","journal-title":"PloS One"},{"key":"2026030314345519700_iqag002-B60","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOL.0b013e32830d5f09","article-title":"Emigration of monocyte-derived cells to lymph nodes during resolution of inflammation and its failure in atherosclerosis","volume":"19","author":"Randolph","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"2026030314345519700_iqag002-B61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(93)80452-Z","article-title":"Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity","volume":"335","author":"Weeds","year":"1993","journal-title":"FEBS Lett"},{"key":"2026030314345519700_iqag002-B62","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar2520","article-title":"Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis","volume":"10","author":"Osborn","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"2026030314345519700_iqag002-B63","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1468-1331.2008.02133.x","article-title":"Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders","volume":"15","author":"Kulakowska","year":"2008","journal-title":"Eur J Neurol"},{"key":"2026030314345519700_iqag002-B64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2377-10-107","article-title":"Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis","volume":"10","author":"Ku\u0142akowska","year":"2010","journal-title":"BMC Neurol"},{"key":"2026030314345519700_iqag002-B65","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/0961203313507985","article-title":"The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation","volume":"22","author":"Hu","year":"2013","journal-title":"Lupus"},{"key":"2026030314345519700_iqag002-B66","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1371\/journal.pgen.0010048","article-title":"Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis","volume":"1","author":"Aidinis","year":"2005","journal-title":"PLoS Genet"},{"key":"2026030314345519700_iqag002-B67","first-page":"218","article-title":"Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy","volume":"32","author":"Genre","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2026030314345519700_iqag002-B68","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1017\/S1047951114002327","article-title":"Plasma gelsolin as a biomarker of acute rheumatic carditis","volume":"25","author":"Argun","year":"2015","journal-title":"Cardiol Young"},{"key":"2026030314345519700_iqag002-B69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.aller.2015.05.005","article-title":"The plasma gelsolin levels in atopic dermatitis: effect of atopy and disease severity","volume":"44","author":"Eke Gungor","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2026030314345519700_iqag002-B70","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s10067-020-04959-y","article-title":"Plasma gelsolin levels in patients with psoriatic arthritis: a possible novel marker","volume":"39","author":"Esawy","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2026030314345519700_iqag002-B71","first-page":"2072","article-title":"The gelsolin level in patients with primary Sjogren\u2019s syndrome","volume":"25","author":"Huang","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026030314345519700_iqag002-B72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43166-021-00103-z","article-title":"Implication of plasma gelsolin in systemic lupus erythematosus patients","volume":"49","author":"Mosaad","year":"2022","journal-title":"Egypt Rheumatol Rehabil"},{"key":"2026030314345519700_iqag002-B73","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.reval.2022.01.003","article-title":"Evaluation of plasma gelsolin level in chronic atopic dermatitis children patients versus adult patients: a case control study","volume":"62","author":"Hamdino","year":"2022","journal-title":"Rev Fr Allergol"},{"key":"2026030314345519700_iqag002-B74","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1177\/1535370213503256","article-title":"Plasma gelsolin levels are decreased and correlate with fibrosis in IgA nephropathy","volume":"238","author":"Han","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"2026030314345519700_iqag002-B75","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.CCM.0000253815.26311.24","article-title":"Plasma gelsolin is a marker and therapeutic agent in animal sepsis","volume":"35","author":"Lee","year":"2007","journal-title":"Crit Care Med"},{"key":"2026030314345519700_iqag002-B76","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/0016-5085(92)91731-I","article-title":"Depression of plasma gelsolin level during acute liver injury","volume":"102","author":"Ito","year":"1992","journal-title":"Gastroenterology"},{"key":"2026030314345519700_iqag002-B77","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med"},{"key":"2026030314345519700_iqag002-B78","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome1","volume":"54","author":"Kontush","year":"2013","journal-title":"J Lipid Res"},{"key":"2026030314345519700_iqag002-B79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.arteri.2014.09.002","article-title":"The pleiotropic role of HDL in autoimmune diseases","volume":"27","author":"Parra","year":"2015","journal-title":"Cl\u00ednica E Investig En Arterioscler"},{"key":"2026030314345519700_iqag002-B80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-3-319-09665-0_14","article-title":"Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functions","volume":"224","author":"Montecucco","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"2026030314345519700_iqag002-B81","doi-asserted-by":"crossref","first-page":"274629","DOI":"10.1155\/2011\/274629","article-title":"Friend turns foe: transformation of anti-inflammatory HDL to proinflammatory HDL during acute-phase response","volume":"2011","author":"G","year":"2011","journal-title":"Cholesterol"},{"key":"2026030314345519700_iqag002-B82","doi-asserted-by":"crossref","first-page":"36158","DOI":"10.1074\/jbc.M110.134130","article-title":"Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-\/-, ApoA-I-\/- mice","volume":"285","author":"Wilhelm","year":"2010","journal-title":"J Biol Chem"},{"key":"2026030314345519700_iqag002-B83","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.4049\/jimmunol.1402870","article-title":"High-density lipoprotein attenuates Th1 and Th17 autoimmune responses by modulating dendritic cell maturation and function","volume":"194","author":"Tiniakou","year":"2015","journal-title":"J Immunol Baltim"},{"key":"2026030314345519700_iqag002-B84","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1161\/CIRCULATIONAHA.110.961193","article-title":"High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide","volume":"122","author":"Suzuki","year":"2010","journal-title":"Circulation"},{"key":"2026030314345519700_iqag002-B85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2012.07.029","article-title":"HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells","volume":"225","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026030314345519700_iqag002-B86","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1194\/jlr.M072835","article-title":"High density lipoproteins selectively promote the survival of human regulatory T cells","volume":"58","author":"Rueda","year":"2017","journal-title":"J Lipid Res"},{"key":"2026030314345519700_iqag002-B87","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.imbio.2011.07.030","article-title":"High-density lipoprotein phospholipids interfere with dendritic cell Th1 functional maturation","volume":"217","author":"Perrin-Cocon","year":"2012","journal-title":"Immunobiology"},{"key":"2026030314345519700_iqag002-B88","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/ATVBAHA.113.302832","article-title":"Inhibition of arthritis in the Lewis rat by apolipoprotein A-I and reconstituted high-density lipoproteins","volume":"34","author":"Wu","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026030314345519700_iqag002-B89","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo","year":"2014","journal-title":"Nat Immunol"},{"key":"2026030314345519700_iqag002-B90","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1373\/clinchem.2018.299636","article-title":"Low HDL cholesterol and high risk of autoimmune disease: two population-based cohort studies including 117341 individuals","volume":"65","author":"Madsen","year":"2019","journal-title":"Clin Chem"},{"key":"2026030314345519700_iqag002-B91","first-page":"1","article-title":"Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus","volume":"17","author":"Rezaieyazdi","year":"2022","journal-title":"ARYA Atheroscler J"},{"key":"2026030314345519700_iqag002-B92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.11472","article-title":"High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus","volume":"50","author":"Posadas-Romero","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2026030314345519700_iqag002-B93","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/rheumatology\/keaa016","article-title":"Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus","volume":"59","author":"L\u00f3pez","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026030314345519700_iqag002-B94","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0961203308093072","article-title":"High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus","volume":"17","author":"Ju\u00e1rez-Rojas","year":"2008","journal-title":"Lupus"},{"key":"2026030314345519700_iqag002-B95","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s100670200127","article-title":"Serum lipoprotein(a) level and its clinical significance in patients with systemic lupus erythematosus","volume":"21","author":"Sari","year":"2002","journal-title":"Clin Rheumatol"},{"key":"2026030314345519700_iqag002-B96","first-page":"2541","volume-title":"Arthritis Rheumatol"},{"key":"2026030314345519700_iqag002-B97","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/art.24677","article-title":"Dysfunctional proinflammatory high-density lipoproteins confer increased risk of atherosclerosis in women with systemic lupus erythematosus","volume":"60","author":"McMahon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2026030314345519700_iqag002-B98","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/art.24802","article-title":"Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis","volume":"60","author":"Charles-Schoeman","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2026030314345519700_iqag002-B99","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/ard.2008.092171","article-title":"Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients","volume":"68","author":"Popa","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2026030314345519700_iqag002-B100","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","article-title":"Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis","volume":"71","author":"Charles-Schoeman","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026030314345519700_iqag002-B101","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M027367","article-title":"Psoriasis alters HDL composition and cholesterol efflux capacity","volume":"53","author":"Holzer","year":"2012","journal-title":"J Lipid Res"},{"key":"2026030314345519700_iqag002-B102","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2012.06.068","article-title":"Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis","volume":"224","author":"Mehta","year":"2012","journal-title":"Atherosclerosis"},{"key":"2026030314345519700_iqag002-B103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026030314345519700_iqag002-B104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12944-016-0229-0","article-title":"High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus","volume":"15","author":"Ga\u00e1l","year":"2016","journal-title":"Lipids Health Dis"},{"key":"2026030314345519700_iqag002-B105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-021-02443-9","article-title":"HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2026030314345519700_iqag002-B106","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00296-004-0580-8","article-title":"Lipoprotein profile in limited systemic sclerosis","volume":"25","author":"Borba","year":"2005","journal-title":"Rheumatol Int"},{"key":"2026030314345519700_iqag002-B107","first-page":"650","article-title":"Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c","volume":"59","author":"Parra","year":"2020","journal-title":"Rheumatol Oxf Engl"},{"key":"2026030314345519700_iqag002-B108","doi-asserted-by":"crossref","first-page":"ofac357","DOI":"10.1093\/ofid\/ofac357","article-title":"Adjunctive recombinant human plasma gelsolin for severe coronavirus disease 2019 pneumonia","volume":"9","author":"DiNubile","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2026030314345519700_iqag002-B109","doi-asserted-by":"crossref","first-page":"e00579","DOI":"10.1128\/AAC.00579-20","article-title":"Safety and pharmacokinetics of recombinant human plasma gelsolin in patients hospitalized for nonsevere community-acquired pneumonia","volume":"64","author":"Tannous","year":"2020","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Oxford Open Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ooim\/advance-article-pdf\/doi\/10.1093\/oxfimm\/iqag002\/66569576\/iqag002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/7\/1\/iqag002\/66569576\/iqag002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ooim\/article-pdf\/7\/1\/iqag002\/66569576\/iqag002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:35:13Z","timestamp":1772566513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ooim\/article\/doi\/10.1093\/oxfimm\/iqag002\/8440771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/oxfimm\/iqag002","relation":{},"ISSN":["2633-6960"],"issn-type":[{"value":"2633-6960","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"iqag002"}}